PTC Therapeutics Stock Price (NASDAQ:PTCT)

Add to My Stocks
$13.16 $0.09 (0.69%) PTCT stock closing price Feb 24, 2017 (Closing)
PTC Therapeutics
24 FEB 2017
amigobulls logo
PTCT hand_up
PTCT vs S&P 500
Closing Price: Feb 24, 2017
$13.16 ( 0.69%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 15.46%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

PTC Therapeutics Snapshot Video

13 6 2

PTCT Stock Details

Prev Close* : $13.07
Market Cap:
Day Low: $12.76
52 Week Low: $4.03
Open: $12.9
Volume: 447083
Day High: $13.28
52 Week High: $16.50

Latest Stock Market News

Latest Articles

PTC Therapeutics News - From Partners

PTCT Stockcharts

View PTCT PE ratio, PS ratio stocks charts and compare with peers.
PTCT Chart
Note: Compare PTC Therapeutics stock price history with the index and industry peers.

PTC Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

PTC Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

PTCT Industry Peers

Company Price Change (%)
Esperion Therapeutics (ESPR)24.290.08 (0.33%)
Spectrum Pharma (SPPI)5.80.09 (1.53%)
Catabasis Pharma (CATB)1.220.03 (2.52%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Prosensa Holding (RNA)18.650 (0%)
Avexis (AVXS)55.10.21 (0.38%)
Vertex Pharma (VRTX)86.070.34 (0.4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.050.9 (28.57%)
La Jolla Pharma (LJPC)19.871.65 (9.06%)
Portola Pharma (PTLA)33.51.34 (4.17%)
ImmunoGen (IMGN)2.710.1 (3.83%)
Egalet (EGLT)4.930.14 (2.92%)
Tetraphase Pharmaceuticals (TTPH)5.330.13 (2.5%)
Achaogen (AKAO)23.650.54 (2.34%)
Top gainers from Medical-Drugs industry
* As of Feb 25, 2017
CompanyPriceChange (%)
AVADEL PHARMA (AVDL)10.270.49 (4.55%)
Ignyta (RXDX)8.70.4 (4.4%)
AcelRx Pharma (ACRX)30.1 (3.23%)
Depomed (DEPO)16.320.51 (3.03%)
Lannett Co (LCI)22.90.65 (2.76%)
MediWound (MDWD)5.850.15 (2.5%)
Valeant (VRX)16.180.4 (2.41%)
Top losers from Medical-Drugs industry
* As of Feb 25, 2017

PTC Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues36.76M25.24M34.69M33.94M105.41M
Net Income-170.44M-93.75M-51.57M-26.23M30.9M
Total Operating Expense203.89M124.65M80.08M60.74M74.82M
view PTC Therapeutics, Inc. income statement
balance sheet20152014201320122011
Total Assets368.04M333.21M151.9M13.07M44.14M
Total Liabilities142.04M34.75M15.36M31.88M68.37M
Shareholders Equity226M298.46M136.54M-18.81M-24.22M
view PTC Therapeutics, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities4.69M13.19M-12.31M-25.12M-57.31M
Net Cash From (Used By) Operating Activities-124.33M-57.27M-46.92M-47.92M-20.76M
Increase (Decrease) In Prop Plant And Equipment-2.72M-4.66M-0.84M-0.18M-0.16M
view PTC Therapeutics, Inc. cashflow statement

PTC Therapeutics, Inc. Stock News - Partner Headlines

PTC Therapeutics Stock Message Board

An investor needs to spend 13.16 to buy PTCT stock, as the closing PTC Therapeutics stock price is 13.16. Looking at PTC Therapeutics market capitalization, which currently stands at 448.54M, we can say that PTCT stock is a Small cap stock. PTC Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that PTC Therapeutics is worth a lot, it will most likely be reflected in an inflated PTC Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 447083 shares were traded with a closing stock price of 13.16 as of 24 Feb, 2017, as can be seen from PTC Therapeutics stock quote. One can view PTC Therapeutics stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. PTC Therapeutics does not pay dividends. PTC Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.